Remove tag deep-learning
article thumbnail

Grand Rounds August 4, 2023: AI & ML: Want to Play a Game? (Eric Perakslis, PhD)

Rethinking Clinical Trials

They use motivation, game design, competition, curiosity, collaboration, challenges, media, and learning to accomplish something. Those NPCs learn from interacting with human intelligence. The key is to have a deep understanding and control over the data being used. The important thing is to learn and adapt to the changes.

article thumbnail

Grand Rounds December 8, 2023: A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication about Goals of Care for Hospitalized Patients with Serious Illness (Ruth Engelberg, PhD; Erin Kross, MD; Robert Lee, MD, MS)

Rethinking Clinical Trials

Learn more Read more in JAMA and a JAMA editorial. The same family of deep learning models is still considered state of the art. Overall prevalence of goals of care discussions is low suggestions opportunity for improvement. Discussion Themes -Within individual physicians, did you see an increase in goals of care discussions?

Trials 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds April 28, 2023: Oxygen-Saturation Targets for Critically Ill Adults Receiving Mechanical Ventilation: An Embedded Cluster-crossover Trial (Matthew W. Semler, MD, MSc)

Rethinking Clinical Trials

Assistant Professor of Medicine and Biomedical Informatics Medical Director, VICTR Center for Learning Healthcare Vanderbilt University Medical Center Slides Keywords Pragmatic Clinical Trials, Cluster-crossover Trial Key Points More than 3 million adults receive invasive mechanical ventilation each year in the U.S. Semler, M.D.,

Trials 130
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 57
article thumbnail

How COVID-19 Impacted the Food Supply Chain For Better and for Worse

XTalks

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. Mikhail noted that 2020 was, consequently, an unprecedented year for deep freezer sales. Machine learning, and what it could do for the industry, can help make informed decisions for what you need,” Agyemang said.

article thumbnail

AI is critical to solving new complexities in drug discovery

Drug Discovery World

It also carries a much higher price tag for failure. We’re quickly learning that for every action there is an equal and opposite reaction in human biology that extends far beyond a single hypothesis. On top of that, pharmaceutical development is extremely complex in itself.

Drugs 52
article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

This biological variability adds complexity, but with that complexity comes the power to choose the targets, the tags and the payloads and select combinations appropriate to the patient to personalize that therapy. There is also potential for using several radiotherapies in combination therapies. Contact our team of experts today.

DNA 66